CSF2 and colitis: ILC3s have been shown to be a dominant source of GM-CSF in the intestine.11,12 Therefore, the enhanced GM-CSF production from Brg1-deficient ILC3s was likely to be a key colitogenic factor for colitis in Rag1−/−Smarca4ΔILC3 mice.